Cardiac amyloidosis has recently garnered substantial attention. Although the advent of noninvasive diagnostic algorithms revolutionized diagnosis, endomyocardial biopsy may still be considered in select cases to determine the amyloidosis subtype definitively. We report a case of a patients with a known mutation causing hereditary apolipoprotein A-I–associated cardiac amyloidosis. (Level of Difficulty: Advanced.)
No takes yet. Share an insight, caveat, or question.
Saleem et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: